Brief: Vaxart Q1 Net Income USD -15.591 Million
13/05/2025 21:05
May 13 (Reuters) - Vaxart Q1 operating expenses USD 35.811 million. Q1 operating income USD -14.935 million Q1 basic EPS USD -0.07 Q1 pretax profit USD -15.496 million
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts